Your browser doesn't support javascript.
loading
Plasma Gel Matrix as a Promising Carrier of Epigallocatechin Gallate for Regenerative Medicine.
Ushiki, Takashi; Mochizuki, Tomoharu; Osawa, Mami; Suzuki, Katsuya; Tsujino, Tetsuhiro; Watanabe, Taisuke; Mourão, Carlos Fernando; Kawase, Tomoyuki.
Afiliação
  • Ushiki T; Department of Transfusion Medicine, Cell Therapy and Regenerative Medicine, Niigata University Medical and Dental Hospital, Niigata 951-8520, Japan.
  • Mochizuki T; Division of Hematology and Oncology, Graduate School of Health Sciences, Niigata University, Niigata 951-9518, Japan.
  • Osawa M; Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University, Niigata 951-8510, Japan.
  • Suzuki K; Department of Orthopaedic Surgery, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan.
  • Tsujino T; Division of Hematology and Oncology, Graduate School of Health Sciences, Niigata University, Niigata 951-9518, Japan.
  • Watanabe T; Department of Transfusion Medicine, Cell Therapy and Regenerative Medicine, Niigata University Medical and Dental Hospital, Niigata 951-8520, Japan.
  • Mourão CF; Private Practice, Hiroshima 732-0066, Japan.
  • Kawase T; Division of Anatomy and Cell Biology of the Hard Tissue, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan.
J Funct Biomater ; 15(4)2024 Apr 10.
Article em En | MEDLINE | ID: mdl-38667555
ABSTRACT
Plasma gel (PG) is a protein matrix prepared from platelet-poor plasma and can be utilized as a drug carrier for controlled release. We previously demonstrated its applicability as a carrier of polyphosphate. Epigallocatechin-3-gallate (EGCG) is the main flavonoid found in green tea and functions as a strong antioxidant. To explore the applicability of PG as an EGCG carrier, we examined the release of EGCG from the PG matrix using an in vitro system. Pooled platelet-poor plasma (PPP) was prepared from four healthy adult male donors, mixed with EGCG, and heated at 75 °C for 10 or 20 min to prepare the PG matrix. The PG-EGCG matrix was incubated in PBS at 37 °C, and the EGCG released into PBS was determined using spectrophotometry. The antioxidant capacity was determined based on the principle of the iodine decolorization reaction. EGCG precipitated and incorporated into the PG matrix during thermal preparation. Trypsin, used to simulate the in vivo degradation of PG, released EGCG from the PG matrix over time. The released EGCG maintained its antioxidant capacity during incubation. These results indicate that thermally prepared PG matrices can be utilized as a promising EGCG carrier in the fields of tissue engineering and regenerative medicine.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Funct Biomater Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Funct Biomater Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão